Cargando…

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners

BACKGROUND: HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated hemoglobin over two to three months, with limited utility in the presence of recent and/or short-term fluctuations in glycemic control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peabody, John, Paculdo, David, Acelajado, M. Czarina, Burgon, Trever, Dahlen, Jeffrey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184171/ https://www.ncbi.nlm.nih.gov/pubmed/32368501 http://dx.doi.org/10.1016/j.jcte.2020.100224

Ejemplares similares

Low Rates of Genetic Testing in Children With Developmental Delays, Intellectual Disability, and Autism Spectrum Disorders
por: Peabody, John, et al.
Publicado: (2015)

Drug-Drug Interaction Assessment and Identification in the Primary Care Setting
por: Peabody, John, et al.
Publicado: (2018)

Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
por: Peabody, John, et al.
Publicado: (2019)

Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
por: Peabody, John W., et al.
Publicado: (2017)

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
por: Peabody, John, et al.
Publicado: (2021)

Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
por: Burgon, Trever, et al.
Publicado: (2021)

Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices
por: Peabody, John, et al.
Publicado: (2016)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study
por: Strong, Jodi, et al.
Publicado: (2021)

Data for serum 1,5 anhydroglucitol concentration in different populations
por: Welter, Marciane, et al.
Publicado: (2018)

1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events
por: Migała, Marta, et al.
Publicado: (2022)

Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care
por: Peabody, John, et al.
Publicado: (2018)

Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
por: Yoo, Ha Yeong, et al.
Publicado: (2015)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Salivary 1,5-Anhydroglucitol and Vitamin Levels in Relation to Caries Risk in Children
por: Syed, Sadatullah, et al.
Publicado: (2019)

Improving Clinical Practice Using a Novel Engagement Approach: Measurement, Benchmarking and Feedback, A Longitudinal Study
por: Peabody, John W., et al.
Publicado: (2016)

Optimal management of hypertension in elderly patients
por: Acelajado, Maria Czarina
Publicado: (2010)

Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality
por: Kira, Sakurako, et al.
Publicado: (2020)

Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
por: Pal, Aparna, et al.
Publicado: (2010)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
por: Lee, Ji-Eun
Publicado: (2015)

Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay
por: Halama, Anna, et al.
Publicado: (2016)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia
por: Diederich, Jennifer, et al.
Publicado: (2023)

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
por: Stettler, Christoph, et al.
Publicado: (2008)

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
por: Su, Gong, et al.
Publicado: (2020)

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay
por: Kedarnath, Priyadarshini Subramaniam, et al.
Publicado: (2023)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
por: Shen, Yun, et al.
Publicado: (2020)

Aldosteronism and Resistant Hypertension
por: Acelajado, Maria Czarina, et al.
Publicado: (2011)

Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study
por: Loomis, Stephanie J., et al.
Publicado: (2019)

1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
por: Seok, Hannah, et al.
Publicado: (2015)

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism
por: Li, Man, et al.
Publicado: (2017)

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker
por: Kappel, Ben A., et al.
Publicado: (2021)

Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
por: Ying, Lingwen, et al.
Publicado: (2021)

Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
por: Yang, Ruiyue, et al.
Publicado: (2022)

An Efficient Electrochemical Biosensor to Determine 1,5-Anhydroglucitol with Persimmon-Tannin-Reduced Graphene Oxide-PtPd Nanocomposites
por: Li, Guiyin, et al.
Publicado: (2023)

Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance
por: Pramodkumar, Thyparambil Aravindakshan, et al.
Publicado: (2016)

Clinical Variation in the Treatment Practices for Patients With Type 2 Diabetes: A Cross‐Sectional Patient Simulation Study Among Primary Care Physicians and Cardiologists
por: De Belen, Enrico, et al.
Publicado: (2023)

Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young
por: Skupien, Jan, et al.
Publicado: (2008)

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population
por: Ying, Lingwen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cs46jjo093tonnl6t7pu50j2v6